The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Recognizing and Managing Chronic Graft-Versus-Host Disease
Open accessAbstract
Chronic graft-versus-host disease (GVHD) is an immune-mediated disorder that occurs frequently after allogeneic hematopoietic cell transplantation (HCT). Most cases are diagnosed within the first year at a median of 4 to 6 months after HCT, but 5–10% of cases are initially diagnosed beyond the first post-transplant year. Chronic GVHD most often involves the skin and mouth, but almost any other organ system can be involved. Correct diagnosis is critical so that appropriate therapy can be started promptly to minimize symptoms and prevent irreversible organ damage. Initial treatment should be with cortico-steroid-based therapy. Optimal secondary treatment as not been established, although a large number of agents may provide benefits. A 2004 NIH conference focused on development of consensus criteria for chronic GVHD. Six papers published in 2005 and 2006 propose consensus definitions for chronic GVHD diagnosis and scoring, pathology, biomarkers, response criteria, supportive care and design of clinical trials. This review will focus on common clinical presentations and principles for managing chronic GVHD. The most frequently used secondary therapies and ongoing trials are summarized. New concepts from the NIH consensus conference are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jagasia, M. H., Greinix, H. T., Arora, M., Williams, K. M., Wolff, D., Cowen, E. W., Palmer, J., Weisdorf, D., Treister, N. S., Cheng, G.-S., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.12.001 · Cited by 5,459
Self-citationFilipovich, A. H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J. R., Lee, S. J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., et al. (2005) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2005.09.004 · Cited by 3,556
Self-citationChronic graft-versus-host disease
Lee, S. J., Vogelsang, G., & Flowers, M. E. D. (2003) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2003.50026 · Cited by 950
Self-citationLong-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation
Socié, G., Stone, J. V., Wingard, J. R., Weisdorf, D., Henslee-Downey, P. J., Bredeson, C., Cahn, J.-Y., Passweg, J. R., Rowlings, P. A., Schouten, H. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410103 · Cited by 698
(2000) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(00)70002-4 · Cited by 607
Pavletic, S. Z., Martin, P., Lee, S. J., Mitchell, S., Jacobsohn, D., Cowen, E. W., Turner, M. L., Akpek, G., Gilman, A., McDonald, G., et al. (2006) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2006.01.008 · Cited by 563
Self-citationLee, S. J. (2002) · Blood · doi:10.1182/blood.v100.2.406 · Cited by 538
Self-citationRituximab for steroid-refractory chronic graft-versus-host disease
Cutler, C., Miklos, D., Kim, H. T., Treister, N., Woo, S.-B., Bienfang, D., Klickstein, L. B., Levin, J., Miller, K., Reynolds, C., et al. (2006) · Blood · doi:10.1182/blood-2006-01-0233 · Cited by 452
Self-citationFlowers, M. E. D., Parker, P. M., Johnston, L. J., Matos, A. V. B., Storer, B., Bensinger, W. I., Storb, R., Appelbaum, F. R., Forman, S. J., Blume, K. G., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0011 · Cited by 421
Self-citationCouriel, D., Carpenter, P. A., Cutler, C., Bolaños-Meade, J., Treister, N. S., Gea-Banacloche, J., Shaughnessy, P., Hymes, S., Kim, S., Wayne, A. S., et al. (2006) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2006.02.003 · Cited by 321
Self-citationKoc, S., Leisenring, W., Flowers, M. E. D., Anasetti, C., Deeg, H. J., Nash, R. A., Sanders, J. E., Witherspoon, R. P., Storb, R., Appelbaum, F. R., et al. (2002) · Blood · doi:10.1182/blood.v100.1.48 · Cited by 283
Self-citationDuration of immunosuppressive treatment for chronic graft-versus-host disease
Stewart, B. L., Storer, B., Storek, J., Deeg, H. J., Storb, R., Hansen, J. A., Appelbaum, F. R., Carpenter, P. A., Sanders, J. E., Kiem, H.-P., et al. (2004) · Blood · doi:10.1182/blood-2004-01-0200 · Cited by 281
Self-citationDevelopment and validation of a scale to measure symptoms of chronic graft-versus-host disease
Lee, S. J., Cook, E. F., Soiffer, R., & Antin, J. H. (2002) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2002.v8.pm12234170 · Cited by 246
Self-citationChronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome
Zecca, M. (2002) · Blood · doi:10.1182/blood-2001-11-0059 · Cited by 223
Thalidomide as salvage therapy for chronic graft-versus-host disease
Parker, P., Chao, N., Nademanee, A., O'Donnell, M., Schmidt, G., Snyder, D., Stein, A., Smith, E., Molina, A., & Stepan, D. (1995) · Blood · doi:10.1182/blood.v86.9.3604.bloodjournal8693604 · Cited by 190
Couriel, D. R., Saliba, R., Escalón, M. P., Hsu, Y., Ghosh, S., Ippoliti, C., Hicks, K., Donato, M., Giralt, S., Khouri, I. F., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05616.x · Cited by 185
Nonmelanoma Skin and Mucosal Cancers After Hematopoietic Cell Transplantation
Leisenring, W., Friedman, D. L., Flowers, M. E. D., Schwartz, J. L., & Deeg, H. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7052 · Cited by 185
Self-citationScarisbrick, J. J., Taylor, P., Holtick, U., Makar, Y., Douglas, K., Berlin, G., Juvonen, E., Marshall, S., & on behalf of the Photopheresis Expert Group (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08415.x · Cited by 174
Jacobs, D. S., & Rosenthal, P. (2007) · Cornea · doi:10.1097/ico.0b013e318155743d · Cited by 174
Treatment of refractory chronic GVHD with rituximab: a GITMO study
Zaja, F., Bacigalupo, A., Patriarca, F., Stanzani, M., Van Lint, M. T., Filì, C., Scimè, R., Milone, G., Falda, M., Vener, C., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705725 · Cited by 170
van Burik, J. H., Carter, S. L., Freifeld, A. G., High, K. P., Godder, K. T., Papanicolaou, G. A., Mendizabal, A. M., Wagner, J. E., Yanovich, S., & Kernan, N. A. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.08.049 · Cited by 164
Cohen, A., Rovelli, A., Merlo, D. F., Lint, M. T. V., Lanino, E., Bresters, D., Ceppi, M., Bocchini, V., Tichelli, A., & Socié, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9276 · Cited by 151
New approaches for preventing and treating chronic graft-versus-host disease
Lee, S. J. (2005) · Blood · doi:10.1182/blood-2004-10-4023 · Cited by 139
Self-citationRapamycin (sirolimus) for treatment of chronic graft-versus-host disease
Johnston, L., Brown, J. W., Shizuru, J. A., Stockerl-Goldstein, K. E., Stuart, M. J., Blume, K. G., Negrin, R. S., & Chao, N. J. A. (2004) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2004.10.004 · Cited by 131
Jagasia, M., Giglia, J. L., Chinratanalab, W., Dixon, S., Chen, H., Frangoul, H., Engelhardt, B. G., Goodman, S. A., Greer, J. P., Kassim, A. A., et al. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.07.001 · Cited by 107
Second Malignancies after Allogeneic Hematopoietic Cell Transplantation
Lowe, T., Bhatia, R., & Somlo, G. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.07.002 · Cited by 98
Cutaneous Manifestations of Chronic Graft-versus-Host Disease
Hymes, S. R., Turner, M. L. C., Champlin, R. E., & Couriel, D. R. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.08.043 · Cited by 88
Individual Physician Practice Variation in Hematopoietic Cell Transplantation
Lee, S. J., Joffe, S., Artz, A. S., Champlin, R. E., Davies, S. M., Jagasia, M., Kernan, N. A., Loberiza, F. R., Soiffer, R. J., & Eapen, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0169 · Cited by 57
Self-citationKulkarni, S., Powles, R., Sirohi, B., Treleaven, J. G., Saso, R. M., Horton, C., Atra, A., Ortín, M., Rudin, C. M., Goyal, S. D., et al. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704033 · Cited by 48
Cited by
Jagasia, M. H., Greinix, H. T., Arora, M., Williams, K. M., Wolff, D., Cowen, E. W., Palmer, J., Weisdorf, D., Treister, N. S., Cheng, G.-S., et al. (2015) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.12.001 · Cited by 5,459
Self-citationMajhail, Rizzo, J. D., Lee, S. J., Aljurf, M., Atsuta, Y., Bonfim, C., Burns, L. J., Chaudhri, N., Davies, S., Okamoto, S., et al. (2012) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20120032 · Cited by 509
Pidala, J., Kurland, B., Chai, X., Majhail, N., Weisdorf, D. J., Pavletic, S., Cutler, C., Jacobsohn, D., Palmer, J., Arai, S., et al. (2011) · Blood · doi:10.1182/blood-2010-11-319509 · Cited by 389
Self-citationHow we treat chronic graft-versus-host disease
Flowers, M. E. D., & Martin, P. J. (2015) · Blood · doi:10.1182/blood-2014-08-551994 · Cited by 371
Self-citationMajhail, N. S., Rizzo, J. D., Lee, S. J., Aljurf, M., Atsuta, Y., Bonfim, C., Burns, L. J., Chaudhri, N., Davies, S., Okamoto, S., et al. (2012) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2011.12.519 · Cited by 363
Self-citation
Metadata
- Authors
- Lee, S. J., & Flowers, M. E. D.
- Venue
- Hematology
- Publisher
- American Society of Hematology
- Published
- 2008-01-01
- Volume
- 2008
- Issue
- 1
- Pages
- 134-141
- ISSN
- 1520-4383 (ISSN-L)
- 1520-4391
- OpenAlex
- W2078062413
- Cited by
- 261
- References
- 30
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.